Monoclonal Antibody Based Products-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Monoclonal Antibody Based Products-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Monoclonal Antibody Based Products industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Monoclonal Antibody Based Products 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Monoclonal Antibody Based Products worldwide and market share by regions, with company and product introduction, position in the Monoclonal Antibody Based Products market
Market status and development trend of Monoclonal Antibody Based Products by types and applications
Cost and profit status of Monoclonal Antibody Based Products, and marketing status
Market growth drivers and challenges
The report segments the global Monoclonal Antibody Based Products market as:
Global Monoclonal Antibody Based Products Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Monoclonal Antibody Based Products Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Murine
Chimeric
Humanized
Human
Global Monoclonal Antibody Based Products Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Therapeutics
Diagnostics
Global Monoclonal Antibody Based Products Market: Manufacturers Segment Analysis (Company and Product introduction, Monoclonal Antibody Based Products Sales Volume, Revenue, Price and Gross Margin):
Amgen
BD Biosciences
Biogen Idec
Biotest
CMC ICOS Biologics
Dendreon
Elan Corporations
Eli Lilly and Company
Genentech
Human Genome Sciences
Immunomedics
Johnson & Johnson
Centocor
Ortho Biotech Products
Medarex
MedImmune
PDL BioPharma
Schering-Plough
Strategic Diagnostics
UCB
Wyeth Pharmaceuticals
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Monoclonal Antibody Based Products-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Monoclonal Antibody Based Products industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Monoclonal Antibody Based Products 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Monoclonal Antibody Based Products worldwide and market share by regions, with company and product introduction, position in the Monoclonal Antibody Based Products market
Market status and development trend of Monoclonal Antibody Based Products by types and applications
Cost and profit status of Monoclonal Antibody Based Products, and marketing status
Market growth drivers and challenges
The report segments the global Monoclonal Antibody Based Products market as:
Global Monoclonal Antibody Based Products Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Monoclonal Antibody Based Products Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Murine
Chimeric
Humanized
Human
Global Monoclonal Antibody Based Products Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Therapeutics
Diagnostics
Global Monoclonal Antibody Based Products Market: Manufacturers Segment Analysis (Company and Product introduction, Monoclonal Antibody Based Products Sales Volume, Revenue, Price and Gross Margin):
Amgen
BD Biosciences
Biogen Idec
Biotest
CMC ICOS Biologics
Dendreon
Elan Corporations
Eli Lilly and Company
Genentech
Human Genome Sciences
Immunomedics
Johnson & Johnson
Centocor
Ortho Biotech Products
Medarex
MedImmune
PDL BioPharma
Schering-Plough
Strategic Diagnostics
UCB
Wyeth Pharmaceuticals
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF MONOCLONAL ANTIBODY BASED PRODUCTS
1.1 Definition of Monoclonal Antibody Based Products in This Report
1.2 Commercial Types of Monoclonal Antibody Based Products
1.2.1 Murine
1.2.2 Chimeric
1.2.3 Humanized
1.2.4 Human
1.3 Downstream Application of Monoclonal Antibody Based Products
1.3.1 Therapeutics
1.3.2 Diagnostics
1.4 Development History of Monoclonal Antibody Based Products
1.5 Market Status and Trend of Monoclonal Antibody Based Products 2013-2023
1.5.1 Global Monoclonal Antibody Based Products Market Status and Trend 2013-2023
1.5.2 Regional Monoclonal Antibody Based Products Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Monoclonal Antibody Based Products 2013-2017
2.2 Sales Market of Monoclonal Antibody Based Products by Regions
2.2.1 Sales Volume of Monoclonal Antibody Based Products by Regions
2.2.2 Sales Value of Monoclonal Antibody Based Products by Regions
2.3 Production Market of Monoclonal Antibody Based Products by Regions
2.4 Global Market Forecast of Monoclonal Antibody Based Products 2018-2023
2.4.1 Global Market Forecast of Monoclonal Antibody Based Products 2018-2023
2.4.2 Market Forecast of Monoclonal Antibody Based Products by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Monoclonal Antibody Based Products by Types
3.2 Sales Value of Monoclonal Antibody Based Products by Types
3.3 Market Forecast of Monoclonal Antibody Based Products by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Monoclonal Antibody Based Products by Downstream Industry
4.2 Global Market Forecast of Monoclonal Antibody Based Products by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Monoclonal Antibody Based Products Market Status by Countries
5.1.1 North America Monoclonal Antibody Based Products Sales by Countries (2013-2017)
5.1.2 North America Monoclonal Antibody Based Products Revenue by Countries (2013-2017)
5.1.3 United States Monoclonal Antibody Based Products Market Status (2013-2017)
5.1.4 Canada Monoclonal Antibody Based Products Market Status (2013-2017)
5.1.5 Mexico Monoclonal Antibody Based Products Market Status (2013-2017)
5.2 North America Monoclonal Antibody Based Products Market Status by Manufacturers
5.3 North America Monoclonal Antibody Based Products Market Status by Type (2013-2017)
5.3.1 North America Monoclonal Antibody Based Products Sales by Type (2013-2017)
5.3.2 North America Monoclonal Antibody Based Products Revenue by Type (2013-2017)
5.4 North America Monoclonal Antibody Based Products Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Monoclonal Antibody Based Products Market Status by Countries
6.1.1 Europe Monoclonal Antibody Based Products Sales by Countries (2013-2017)
6.1.2 Europe Monoclonal Antibody Based Products Revenue by Countries (2013-2017)
6.1.3 Germany Monoclonal Antibody Based Products Market Status (2013-2017)
6.1.4 UK Monoclonal Antibody Based Products Market Status (2013-2017)
6.1.5 France Monoclonal Antibody Based Products Market Status (2013-2017)
6.1.6 Italy Monoclonal Antibody Based Products Market Status (2013-2017)
6.1.7 Russia Monoclonal Antibody Based Products Market Status (2013-2017)
6.1.8 Spain Monoclonal Antibody Based Products Market Status (2013-2017)
6.1.9 Benelux Monoclonal Antibody Based Products Market Status (2013-2017)
6.2 Europe Monoclonal Antibody Based Products Market Status by Manufacturers
6.3 Europe Monoclonal Antibody Based Products Market Status by Type (2013-2017)
6.3.1 Europe Monoclonal Antibody Based Products Sales by Type (2013-2017)
6.3.2 Europe Monoclonal Antibody Based Products Revenue by Type (2013-2017)
6.4 Europe Monoclonal Antibody Based Products Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Monoclonal Antibody Based Products Market Status by Countries
7.1.1 Asia Pacific Monoclonal Antibody Based Products Sales by Countries (2013-2017)
7.1.2 Asia Pacific Monoclonal Antibody Based Products Revenue by Countries (2013-2017)
7.1.3 China Monoclonal Antibody Based Products Market Status (2013-2017)
7.1.4 Japan Monoclonal Antibody Based Products Market Status (2013-2017)
7.1.5 India Monoclonal Antibody Based Products Market Status (2013-2017)
7.1.6 Southeast Asia Monoclonal Antibody Based Products Market Status (2013-2017)
7.1.7 Australia Monoclonal Antibody Based Products Market Status (2013-2017)
7.2 Asia Pacific Monoclonal Antibody Based Products Market Status by Manufacturers
7.3 Asia Pacific Monoclonal Antibody Based Products Market Status by Type (2013-2017)
7.3.1 Asia Pacific Monoclonal Antibody Based Products Sales by Type (2013-2017)
7.3.2 Asia Pacific Monoclonal Antibody Based Products Revenue by Type (2013-2017)
7.4 Asia Pacific Monoclonal Antibody Based Products Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Monoclonal Antibody Based Products Market Status by Countries
8.1.1 Latin America Monoclonal Antibody Based Products Sales by Countries (2013-2017)
8.1.2 Latin America Monoclonal Antibody Based Products Revenue by Countries (2013-2017)
8.1.3 Brazil Monoclonal Antibody Based Products Market Status (2013-2017)
8.1.4 Argentina Monoclonal Antibody Based Products Market Status (2013-2017)
8.1.5 Colombia Monoclonal Antibody Based Products Market Status (2013-2017)
8.2 Latin America Monoclonal Antibody Based Products Market Status by Manufacturers
8.3 Latin America Monoclonal Antibody Based Products Market Status by Type (2013-2017)
8.3.1 Latin America Monoclonal Antibody Based Products Sales by Type (2013-2017)
8.3.2 Latin America Monoclonal Antibody Based Products Revenue by Type (2013-2017)
8.4 Latin America Monoclonal Antibody Based Products Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Monoclonal Antibody Based Products Market Status by Countries
9.1.1 Middle East and Africa Monoclonal Antibody Based Products Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Monoclonal Antibody Based Products Revenue by Countries (2013-2017)
9.1.3 Middle East Monoclonal Antibody Based Products Market Status (2013-2017)
9.1.4 Africa Monoclonal Antibody Based Products Market Status (2013-2017)
9.2 Middle East and Africa Monoclonal Antibody Based Products Market Status by Manufacturers
9.3 Middle East and Africa Monoclonal Antibody Based Products Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Monoclonal Antibody Based Products Sales by Type (2013-2017)
9.3.2 Middle East and Africa Monoclonal Antibody Based Products Revenue by Type (2013-2017)
9.4 Middle East and Africa Monoclonal Antibody Based Products Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF MONOCLONAL ANTIBODY BASED PRODUCTS
10.1 Global Economy Situation and Trend Overview
10.2 Monoclonal Antibody Based Products Downstream Industry Situation and Trend Overview
CHAPTER 11 MONOCLONAL ANTIBODY BASED PRODUCTS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Monoclonal Antibody Based Products by Major Manufacturers
11.2 Production Value of Monoclonal Antibody Based Products by Major Manufacturers
11.3 Basic Information of Monoclonal Antibody Based Products by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Monoclonal Antibody Based Products Major Manufacturer
11.3.2 Employees and Revenue Level of Monoclonal Antibody Based Products Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 MONOCLONAL ANTIBODY BASED PRODUCTS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Amgen
12.1.1 Company profile
12.1.2 Representative Monoclonal Antibody Based Products Product
12.1.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Amgen
12.2 BD Biosciences
12.2.1 Company profile
12.2.2 Representative Monoclonal Antibody Based Products Product
12.2.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of BD Biosciences
12.3 Biogen Idec
12.3.1 Company profile
12.3.2 Representative Monoclonal Antibody Based Products Product
12.3.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Biogen Idec
12.4 Biotest
12.4.1 Company profile
12.4.2 Representative Monoclonal Antibody Based Products Product
12.4.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Biotest
12.5 CMC ICOS Biologics
12.5.1 Company profile
12.5.2 Representative Monoclonal Antibody Based Products Product
12.5.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of CMC ICOS Biologics
12.6 Dendreon
12.6.1 Company profile
12.6.2 Representative Monoclonal Antibody Based Products Product
12.6.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Dendreon
12.7 Elan Corporations
12.7.1 Company profile
12.7.2 Representative Monoclonal Antibody Based Products Product
12.7.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Elan Corporations
12.8 Eli Lilly and Company
12.8.1 Company profile
12.8.2 Representative Monoclonal Antibody Based Products Product
12.8.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Eli Lilly and Company
12.9 Genentech
12.9.1 Company profile
12.9.2 Representative Monoclonal Antibody Based Products Product
12.9.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Genentech
12.10 Human Genome Sciences
12.10.1 Company profile
12.10.2 Representative Monoclonal Antibody Based Products Product
12.10.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Human Genome Sciences
12.11 Immunomedics
12.11.1 Company profile
12.11.2 Representative Monoclonal Antibody Based Products Product
12.11.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Immunomedics
12.12 Johnson & Johnson
12.12.1 Company profile
12.12.2 Representative Monoclonal Antibody Based Products Product
12.12.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Johnson & Johnson
12.13 Centocor
12.13.1 Company profile
12.13.2 Representative Monoclonal Antibody Based Products Product
12.13.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Centocor
12.14 Ortho Biotech Products
12.14.1 Company profile
12.14.2 Representative Monoclonal Antibody Based Products Product
12.14.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Ortho Biotech Products
12.15 Medarex
12.15.1 Company profile
12.15.2 Representative Monoclonal Antibody Based Products Product
12.15.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Medarex
12.16 MedImmune
12.17 PDL BioPharma
12.18 Schering-Plough
12.19 Strategic Diagnostics
12.20 UCB
12.21 Wyeth Pharmaceuticals
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MONOCLONAL ANTIBODY BASED PRODUCTS
13.1 Industry Chain of Monoclonal Antibody Based Products
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF MONOCLONAL ANTIBODY BASED PRODUCTS
14.1 Cost Structure Analysis of Monoclonal Antibody Based Products
14.2 Raw Materials Cost Analysis of Monoclonal Antibody Based Products
14.3 Labor Cost Analysis of Monoclonal Antibody Based Products
14.4 Manufacturing Expenses Analysis of Monoclonal Antibody Based Products
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Monoclonal Antibody Based Products in This Report
1.2 Commercial Types of Monoclonal Antibody Based Products
1.2.1 Murine
1.2.2 Chimeric
1.2.3 Humanized
1.2.4 Human
1.3 Downstream Application of Monoclonal Antibody Based Products
1.3.1 Therapeutics
1.3.2 Diagnostics
1.4 Development History of Monoclonal Antibody Based Products
1.5 Market Status and Trend of Monoclonal Antibody Based Products 2013-2023
1.5.1 Global Monoclonal Antibody Based Products Market Status and Trend 2013-2023
1.5.2 Regional Monoclonal Antibody Based Products Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Monoclonal Antibody Based Products 2013-2017
2.2 Sales Market of Monoclonal Antibody Based Products by Regions
2.2.1 Sales Volume of Monoclonal Antibody Based Products by Regions
2.2.2 Sales Value of Monoclonal Antibody Based Products by Regions
2.3 Production Market of Monoclonal Antibody Based Products by Regions
2.4 Global Market Forecast of Monoclonal Antibody Based Products 2018-2023
2.4.1 Global Market Forecast of Monoclonal Antibody Based Products 2018-2023
2.4.2 Market Forecast of Monoclonal Antibody Based Products by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Monoclonal Antibody Based Products by Types
3.2 Sales Value of Monoclonal Antibody Based Products by Types
3.3 Market Forecast of Monoclonal Antibody Based Products by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Monoclonal Antibody Based Products by Downstream Industry
4.2 Global Market Forecast of Monoclonal Antibody Based Products by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Monoclonal Antibody Based Products Market Status by Countries
5.1.1 North America Monoclonal Antibody Based Products Sales by Countries (2013-2017)
5.1.2 North America Monoclonal Antibody Based Products Revenue by Countries (2013-2017)
5.1.3 United States Monoclonal Antibody Based Products Market Status (2013-2017)
5.1.4 Canada Monoclonal Antibody Based Products Market Status (2013-2017)
5.1.5 Mexico Monoclonal Antibody Based Products Market Status (2013-2017)
5.2 North America Monoclonal Antibody Based Products Market Status by Manufacturers
5.3 North America Monoclonal Antibody Based Products Market Status by Type (2013-2017)
5.3.1 North America Monoclonal Antibody Based Products Sales by Type (2013-2017)
5.3.2 North America Monoclonal Antibody Based Products Revenue by Type (2013-2017)
5.4 North America Monoclonal Antibody Based Products Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Monoclonal Antibody Based Products Market Status by Countries
6.1.1 Europe Monoclonal Antibody Based Products Sales by Countries (2013-2017)
6.1.2 Europe Monoclonal Antibody Based Products Revenue by Countries (2013-2017)
6.1.3 Germany Monoclonal Antibody Based Products Market Status (2013-2017)
6.1.4 UK Monoclonal Antibody Based Products Market Status (2013-2017)
6.1.5 France Monoclonal Antibody Based Products Market Status (2013-2017)
6.1.6 Italy Monoclonal Antibody Based Products Market Status (2013-2017)
6.1.7 Russia Monoclonal Antibody Based Products Market Status (2013-2017)
6.1.8 Spain Monoclonal Antibody Based Products Market Status (2013-2017)
6.1.9 Benelux Monoclonal Antibody Based Products Market Status (2013-2017)
6.2 Europe Monoclonal Antibody Based Products Market Status by Manufacturers
6.3 Europe Monoclonal Antibody Based Products Market Status by Type (2013-2017)
6.3.1 Europe Monoclonal Antibody Based Products Sales by Type (2013-2017)
6.3.2 Europe Monoclonal Antibody Based Products Revenue by Type (2013-2017)
6.4 Europe Monoclonal Antibody Based Products Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Monoclonal Antibody Based Products Market Status by Countries
7.1.1 Asia Pacific Monoclonal Antibody Based Products Sales by Countries (2013-2017)
7.1.2 Asia Pacific Monoclonal Antibody Based Products Revenue by Countries (2013-2017)
7.1.3 China Monoclonal Antibody Based Products Market Status (2013-2017)
7.1.4 Japan Monoclonal Antibody Based Products Market Status (2013-2017)
7.1.5 India Monoclonal Antibody Based Products Market Status (2013-2017)
7.1.6 Southeast Asia Monoclonal Antibody Based Products Market Status (2013-2017)
7.1.7 Australia Monoclonal Antibody Based Products Market Status (2013-2017)
7.2 Asia Pacific Monoclonal Antibody Based Products Market Status by Manufacturers
7.3 Asia Pacific Monoclonal Antibody Based Products Market Status by Type (2013-2017)
7.3.1 Asia Pacific Monoclonal Antibody Based Products Sales by Type (2013-2017)
7.3.2 Asia Pacific Monoclonal Antibody Based Products Revenue by Type (2013-2017)
7.4 Asia Pacific Monoclonal Antibody Based Products Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Monoclonal Antibody Based Products Market Status by Countries
8.1.1 Latin America Monoclonal Antibody Based Products Sales by Countries (2013-2017)
8.1.2 Latin America Monoclonal Antibody Based Products Revenue by Countries (2013-2017)
8.1.3 Brazil Monoclonal Antibody Based Products Market Status (2013-2017)
8.1.4 Argentina Monoclonal Antibody Based Products Market Status (2013-2017)
8.1.5 Colombia Monoclonal Antibody Based Products Market Status (2013-2017)
8.2 Latin America Monoclonal Antibody Based Products Market Status by Manufacturers
8.3 Latin America Monoclonal Antibody Based Products Market Status by Type (2013-2017)
8.3.1 Latin America Monoclonal Antibody Based Products Sales by Type (2013-2017)
8.3.2 Latin America Monoclonal Antibody Based Products Revenue by Type (2013-2017)
8.4 Latin America Monoclonal Antibody Based Products Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Monoclonal Antibody Based Products Market Status by Countries
9.1.1 Middle East and Africa Monoclonal Antibody Based Products Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Monoclonal Antibody Based Products Revenue by Countries (2013-2017)
9.1.3 Middle East Monoclonal Antibody Based Products Market Status (2013-2017)
9.1.4 Africa Monoclonal Antibody Based Products Market Status (2013-2017)
9.2 Middle East and Africa Monoclonal Antibody Based Products Market Status by Manufacturers
9.3 Middle East and Africa Monoclonal Antibody Based Products Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Monoclonal Antibody Based Products Sales by Type (2013-2017)
9.3.2 Middle East and Africa Monoclonal Antibody Based Products Revenue by Type (2013-2017)
9.4 Middle East and Africa Monoclonal Antibody Based Products Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF MONOCLONAL ANTIBODY BASED PRODUCTS
10.1 Global Economy Situation and Trend Overview
10.2 Monoclonal Antibody Based Products Downstream Industry Situation and Trend Overview
CHAPTER 11 MONOCLONAL ANTIBODY BASED PRODUCTS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Monoclonal Antibody Based Products by Major Manufacturers
11.2 Production Value of Monoclonal Antibody Based Products by Major Manufacturers
11.3 Basic Information of Monoclonal Antibody Based Products by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Monoclonal Antibody Based Products Major Manufacturer
11.3.2 Employees and Revenue Level of Monoclonal Antibody Based Products Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 MONOCLONAL ANTIBODY BASED PRODUCTS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Amgen
12.1.1 Company profile
12.1.2 Representative Monoclonal Antibody Based Products Product
12.1.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Amgen
12.2 BD Biosciences
12.2.1 Company profile
12.2.2 Representative Monoclonal Antibody Based Products Product
12.2.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of BD Biosciences
12.3 Biogen Idec
12.3.1 Company profile
12.3.2 Representative Monoclonal Antibody Based Products Product
12.3.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Biogen Idec
12.4 Biotest
12.4.1 Company profile
12.4.2 Representative Monoclonal Antibody Based Products Product
12.4.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Biotest
12.5 CMC ICOS Biologics
12.5.1 Company profile
12.5.2 Representative Monoclonal Antibody Based Products Product
12.5.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of CMC ICOS Biologics
12.6 Dendreon
12.6.1 Company profile
12.6.2 Representative Monoclonal Antibody Based Products Product
12.6.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Dendreon
12.7 Elan Corporations
12.7.1 Company profile
12.7.2 Representative Monoclonal Antibody Based Products Product
12.7.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Elan Corporations
12.8 Eli Lilly and Company
12.8.1 Company profile
12.8.2 Representative Monoclonal Antibody Based Products Product
12.8.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Eli Lilly and Company
12.9 Genentech
12.9.1 Company profile
12.9.2 Representative Monoclonal Antibody Based Products Product
12.9.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Genentech
12.10 Human Genome Sciences
12.10.1 Company profile
12.10.2 Representative Monoclonal Antibody Based Products Product
12.10.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Human Genome Sciences
12.11 Immunomedics
12.11.1 Company profile
12.11.2 Representative Monoclonal Antibody Based Products Product
12.11.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Immunomedics
12.12 Johnson & Johnson
12.12.1 Company profile
12.12.2 Representative Monoclonal Antibody Based Products Product
12.12.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Johnson & Johnson
12.13 Centocor
12.13.1 Company profile
12.13.2 Representative Monoclonal Antibody Based Products Product
12.13.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Centocor
12.14 Ortho Biotech Products
12.14.1 Company profile
12.14.2 Representative Monoclonal Antibody Based Products Product
12.14.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Ortho Biotech Products
12.15 Medarex
12.15.1 Company profile
12.15.2 Representative Monoclonal Antibody Based Products Product
12.15.3 Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin of Medarex
12.16 MedImmune
12.17 PDL BioPharma
12.18 Schering-Plough
12.19 Strategic Diagnostics
12.20 UCB
12.21 Wyeth Pharmaceuticals
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MONOCLONAL ANTIBODY BASED PRODUCTS
13.1 Industry Chain of Monoclonal Antibody Based Products
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF MONOCLONAL ANTIBODY BASED PRODUCTS
14.1 Cost Structure Analysis of Monoclonal Antibody Based Products
14.2 Raw Materials Cost Analysis of Monoclonal Antibody Based Products
14.3 Labor Cost Analysis of Monoclonal Antibody Based Products
14.4 Manufacturing Expenses Analysis of Monoclonal Antibody Based Products
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
